Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 42708-141

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 42708-141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (42708 141 30)

Label for Atorvastatin Calcium Tablet, 20 mg, containing 30 film-coated tablets. The label includes dosage instructions left blank for customization, storage instructions to keep at controlled room temperature, and warnings to keep the container tightly closed and out of reach of children. Distributed by QPharma, Inc.*

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A line chart comparing cumulative incidence percentage over time in years for Atorvastatin versus placebo. The chart shows two lines: a solid line for Atorvastatin and a dashed line for placebo, with incidence increasing over approximately 3.5 years. A hazard ratio (HR) of 0.64 with confidence interval (0.50-0.83) and p-value 0.0005 is indicated, suggesting a difference between the two groups.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

A line graph showing cumulative hazard percentage over time comparing atorvastatin and placebo groups. The x-axis represents time in years up to four years of follow-up, and the y-axis represents cumulative hazard percentage. The atorvastatin group is indicated by a solid line showing a lower cumulative hazard compared to the placebo group, represented by a dotted line. A hazard ratio (HR) of 0.63 with a 95% confidence interval (0.48-0.83) and a p-value of 0.001 is displayed on the graph.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line graph showing the percentage of subjects experiencing an event over time to first major cardiovascular endpoint in years. It compares two doses of Atorvastatin, 10 mg (dashed line) and 80 mg (solid line), with time on the x-axis from 0 to 5 years, and percentage of subjects on the y-axis up to 0.2%. The graph includes a hazard ratio (HR) of 0.78 with confidence interval 0.69-0.89 and a p-value of 0.0002.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure of atorvastatin calcium, illustrating the molecular arrangement of the active ingredient with calcium ion and hydrate molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.